Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): Real world outcomes in a multicenter retrospective study Meeting Abstract
| Authors: | Qualls, D.; Buege, M. J.; Dao, P.; Caimi, P. F.; Rutherford, S. C.; Wehmeyer, G.; Romancik, J. T.; Leslie, L. A.; Merrill, M. H.; Crombie, J. L.; Amoozgar, B.; Kahl, B. S.; Bond, D. A.; Maddocks, K. J.; Okwali, M.; Seshan, V.; Salles, G.; Batlevi, C. L. |
| Abstract Title: | Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): Real world outcomes in a multicenter retrospective study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 787 |
| End Page: | 789 |
| Language: | English |
| ACCESSION: | WOS:000893223200323 |
| DOI: | 10.1182/blood-2022-167620 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work